Abstract
Implantable cardioverter defibrillator implantation in patients with atrial fibrillation (AF) is complicated by the need for anticoagulation during defibrillation testing. In this retrospective study, we evaluated the factors associated with successful cardioversion of AF during ventricular defibrillation testing and the safety of our local anticoagulation protocol.
| Original language | English |
|---|---|
| Journal | Europace |
| DOIs | |
| Publication status | Published - 23 Jun 2009 |